IL1RL1 and Myocardial fibrosis: Natriuretic peptides are relevant for diagnosis and prognosis in HF patients, and biomarkers of myocardial injury (cTnI) and myocardial fibrosis (Galectin-3 and ST2) are used for risk stratification [58].